Literature DB >> 22523384

Alternative splicing controlled by heterogeneous nuclear ribonucleoprotein L regulates development, proliferation, and migration of thymic pre-T cells.

Marie-Claude Gaudreau1, Florian Heyd, Rachel Bastien, Brian Wilhelm, Tarik Möröy.   

Abstract

The regulation of posttranscriptional modifications of pre-mRNA by alternative splicing is important for cellular function, development, and immunity. The receptor tyrosine phosphatase CD45, which is expressed on all hematopoietic cells, is known for its role in the development and activation of T cells. CD45 is known to be alternatively spliced, a process that is partially regulated by heterogeneous nuclear ribonucleoprotein (hnRNP) L. To investigate the role of hnRNP L further, we have generated conditional hnRNP L knockout mice and found that LckCre-mediated deletion of hnRNP L results in a decreased thymic cellularity caused by a partial block at the transition stage between double-negative 4 and double-positive cells. In addition, hnRNP L(-/-) thymocytes express aberrant levels of the CD45RA splice isoforms and show high levels of phosphorylated Lck at the activator tyrosine Y394, but lack phosphorylation of the inhibitory tyrosine Y505. This indicated an increased basal Lck activity and correlated with higher proliferation rates of double-negative 4 cells in hnRNP L(-/-) mice. Deletion of hnRNP L also blocked the migration and egress of single-positive thymocytes to peripheral lymphoid organs in response to sphingosine-1-phosphate and the chemokines CCL21 and CXCL12 very likely as a result of aberrant splicing of genes encoding GTPase regulators and proteins affecting cytoskeletal organization. Our results indicate that hnRNP L regulates T cell differentiation and migration by regulating pre-TCR and chemokine receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523384     DOI: 10.4049/jimmunol.1103142

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

1.  Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.

Authors:  E Ilker Ozay; Sudarvili Shanthalingam; Joe A Torres; Barbara A Osborne; Gregory N Tew; Lisa M Minter
Journal:  Mol Ther       Date:  2020-06-15       Impact factor: 11.454

2.  Transcriptome-wide RNA interaction profiling reveals physical and functional targets of hnRNP L in human T cells.

Authors:  Ganesh Shankarling; Brian S Cole; Michael J Mallory; Kristen W Lynch
Journal:  Mol Cell Biol       Date:  2013-10-28       Impact factor: 4.272

Review 3.  Post-transcriptional coordination of immunological responses by RNA-binding proteins.

Authors:  Panagiota Kafasla; Antonis Skliris; Dimitris L Kontoyiannis
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

Review 4.  Alternative splicing as a regulator of development and tissue identity.

Authors:  Francisco E Baralle; Jimena Giudice
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-10       Impact factor: 94.444

5.  Differential Interleukin-2 Transcription Kinetics Render Mouse but Not Human T Cells Vulnerable to Splicing Inhibition Early after Activation.

Authors:  Debojit Bose; Alexander Neumann; Bernd Timmermann; Stefan Meinke; Florian Heyd
Journal:  Mol Cell Biol       Date:  2019-07-29       Impact factor: 4.272

6.  TCR Signal Strength Regulates Akt Substrate Specificity To Induce Alternate Murine Th and T Regulatory Cell Differentiation Programs.

Authors:  William F Hawse; William C Boggess; Penelope A Morel
Journal:  J Immunol       Date:  2017-06-09       Impact factor: 5.422

7.  High diversification of CD94 by alternative splicing in New World primates.

Authors:  John A Galindo; Luis F Cadavid
Journal:  Immunogenetics       Date:  2013-01-31       Impact factor: 2.846

8.  The Bromodomain Protein 4 Contributes to the Regulation of Alternative Splicing.

Authors:  Sheetal Uppal; Anne Gegonne; Qingrong Chen; Petria S Thompson; Dan Cheng; Jie Mu; Daoud Meerzaman; Hari S Misra; Dinah S Singer
Journal:  Cell Rep       Date:  2019-11-19       Impact factor: 9.423

Review 9.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.

Authors:  Nicole M Martinez; Kristen W Lynch
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

10.  Comparison of predicted and actual consequences of missense mutations.

Authors:  Lisa A Miosge; Matthew A Field; Yovina Sontani; Vicky Cho; Simon Johnson; Anna Palkova; Bhavani Balakishnan; Rong Liang; Yafei Zhang; Stephen Lyon; Bruce Beutler; Belinda Whittle; Edward M Bertram; Anselm Enders; Christopher C Goodnow; T Daniel Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.